Source: International Congress 2014 – COPD markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Buhl, C. P. Criée, P. Kardos, C. Vogelmeier, H. Worth (Mainz, Bovenden, Frankfurt am Main, Marburg, Fuerth, Germany). What are common COPD symptoms in a real-life setting? The German DACCORD registry. Eur Respir J 2014; 44: Suppl. 58, 4736

Member's Comments

No comment yet.

Related content which might interest you: Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Drug treatment in a German real-life COPD cohort (DACCORD) Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Dissociation between clinical trial inclusion and exclusion criteria for trials in severe asthma and the reality of the patient population Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Combination therapy versus separate therapy in real-life primary care asthma patients Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Are muti-disciplinary teams helpful in managing respiratory referrals? Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1 Year: 2014 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic Source: International Congress 2014 – COPD exacerbations Year: 2014 COPD patients' expectations of ICS/LABA therapy Source: International Congress 2014 – Management of COPD in primary care Year: 2014 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 The impact of a specialist multi-disciplinary approach on burden of frequent asthma admissions Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 Routine IMT within COPD Rehabilitation (RIMTCORE-RCT): Are there subgroups with clinical benefits? Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases Year: 2016